How should sponsors review contract manufacturer batch records?
By Savi C., Co-Founder · Published Nov 16, 2026
Who is responsible for what
FDA treats a contract facility as an extension of the manufacturer’s own facility (21 CFR 200.10(b)). The contract site’s quality unit approves or rejects the results of its own operations. The owner’s quality unit approves or rejects the product, including for final release. The 2016 guidance is explicit that no party can delegate its CGMP responsibilities through a quality agreement or any other means.
The guidance illustrates this with a batch record case. A contract site’s batch records did not document the addition of reclaimed powder, and the site argued the records met the quality agreement. FDA’s view was that a batch record that does not reflect the actual process violates CGMP regardless of what the agreement says, and that the owner may also be cited for failing to oversee the contract facility.
EU GMP Chapter 7 adds two points that shape day-to-day review. All records related to outsourced activities, including manufacturing, analytical and distribution records, should be kept by or be available to the contract giver (7.16). And the contract giver’s quality system must state how the Qualified Person certifying each batch exercises full responsibility. ICH Q10 section 2.7 frames the same duty as monitoring and review of the contract acceptor’s performance.
What the quality agreement should settle before the first batch
FDA’s guidance recommends the agreement define document review and approval, deviation reporting and change control. These are the review questions each clause answers.
Agreement topic
Document review and approval
What it decides for batch record review
Which party approves the master batch record and its revisions, so the sponsor knows which version the executed record must match
Agreement topic
Deviation reporting
What it decides for batch record review
How and when the contract site reports deviations, and which ones the sponsor must approve before the batch can be released
Agreement topic
Change control
What it decides for batch record review
Which changes need sponsor approval before implementation, so an unapproved change shows up as an exception in review
Agreement topic
Laboratory results
What it decides for batch record review
How all test results, including invalidated and out-of-specification results, reach the owner for the disposition decision
Agreement topic
Original records and true copies
What it decides for batch record review
Which party holds originals, how true copies are made, and how quickly records can be produced for inspection
Agreement topic
Product release
What it decides for batch record review
The sequence of contract site approval and owner disposition, stated so neither side assumes the other did the check
Sponsor checklist for each contract batch record
Is this the right record
- The master batch record revision used matches the revision the sponsor approved for that manufacture date
- Batch number follows the numbering scheme defined in the agreement or product appendix
- The copy received is complete: page count matches the issued record, attachments and printouts included
- Where a scanned copy is reviewed, it is a true copy under the agreement, not an unverified extract
Does it match what was approved
- Materials and lot numbers match approved suppliers and the bill of materials
- Critical process parameters and in-process results recorded and inside the limits in the sponsor’s specification
- Yields and reconciliations calculated correctly and inside the stated range
- No step performed, added or omitted that the master record does not describe
Were exceptions handled as agreed
- Every deviation in the record was reported to the sponsor within the agreed timeframe
- Deviations requiring sponsor approval carry that approval before disposition
- Any change affecting the batch went through change control at the level the agreement requires
- Laboratory results, including any OOS investigation, are complete and attached
Release
- The contract site’s quality unit approval is recorded before the sponsor disposition
- The sponsor disposition is made by the sponsor’s quality unit or QP, not inferred from the site approval
- Findings from this batch feed the sponsor’s ongoing review of the contract site’s performance
How Litewave fits
Sponsors often receive contract batch records as scanned PDFs, which makes a full page-by-page check slow. Litewave reads paper or electronic records, checks every entry against your master record and specifications, and shows QA only the exceptions, each linked to the page it came from. Litewave proposes, qualified people approve: the disposition stays with the sponsor’s quality unit. For device programs, see the related guide How should contract manufacturers handle DHR review across multiple device customers?
Questions we get asked
Can a sponsor rely on the contract manufacturer’s batch record review?
It can use it, but not substitute it for its own decision. The owner’s quality unit remains responsible for approving or rejecting the product, and FDA’s guidance says a quality agreement does not change that. How deeply the sponsor re-reviews each record is a risk-based decision documented in its own procedures.
Does the quality agreement have to be a separate document?
FDA recommends keeping the quality agreement separate from commercial contracts, and says it intends to review quality agreements during inspections. EU GMP Chapter 7 requires a written contract that clearly establishes each party’s duties.
What happens if a contract site’s batch record follows the agreement but not the real process?
FDA addressed this directly in its 2016 guidance: a batch record that does not accurately reflect the manufacturing process violates CGMP, even if it is consistent with the quality agreement, and the owner may be cited for failing to oversee the site.
